Trials / Conditions / Relapsed Acute Myelogenous Leukemia
Relapsed Acute Myelogenous Leukemia
4 registered clinical trials studyying Relapsed Acute Myelogenous Leukemia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia NCT07014449 | Hangzhou Weben Pharma Co., Ltd | Phase 1 |
| Completed | Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML NCT03081780 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Terminated | Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia NCT01743807 | Therapeutic Advances in Childhood Leukemia Consortium | Phase 1 |
| Terminated | T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) NCT00939653 | Therapeutic Advances in Childhood Leukemia Consortium | Phase 2 |